Treat-to-Target in Ulcerative Colitis: How Soon Is Now?

J Clin Med · 2026 · PMC12841710 · PMID 41598696

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nearly significantno p-value reported

Additionally, a nearly significant greater reduction in median FCP levels, adjusted for baseline values, was observed with dose escalation (−70 μg/g [IQR −378 to 4] vs. −11 μg/g [IQR −231 to 101], p = 0.06).

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.